Abstract: A pharmaceutical composition useful in the treatment or prevention of transgenic xenograft rejection comprising immunosuppressant compounds selected from the group consisting of an IL-2 transcription inhibitor and immunosuppressant compounds that immunosuppress for B-cell-mediated or antibody-mediated rejection of xenografts, and pharmaceutically acceptable diluents or carriers, and a method of preventing hyperacute rejection, reducing early graft damage, improving early xenograft function and promoting long term survival of said transgenic xenografts comprising the steps of i) contacting the body fluid removed from a human recipient with a xenoantigenic material which is bound to a biocompatible solid support, ii) reintroducing the treated body fluid into the recipient, and iii) treating the recipient with said pharmaceutical composition.

Abstract: A system is disclosed in which a data processing device is completely synchronized with a messaging service. One embodiment of the system comprises a wireless data processing device; a messaging service to maintain messages and other information on behalf of a user; and synchronization logic for maintaining synchronization of the messages and other information between the wireless device and the messaging service.

Abstract: A system is disclosed in which a data processing device is completely synchronized with a messaging service. One embodiment of the system comprises a wireless data processing device; a messaging service to maintain messages and other information on behalf of a user; and synchronization logic for maintaining synchronization of the messages and other information between the wireless device and the messaging service.

Abstract: A system is disclosed in which a data processing device is completely synchronized with a messaging service. One embodiment of the system comprises a wireless data processing device; a messaging service to maintain messages and other information on behalf of a user; and synchronization logic for maintaining synchronization of the messages and other information between the wireless device and the messaging service.

Abstract: A system is disclosed in which a data processing device is completely synchronized with a messaging service. One embodiment of the system comprises a wireless data processing device; a messaging service to maintain messages and other information on behalf of a user; and synchronization logic for maintaining synchronization of the messages and other information between the wireless device and the messaging service.

Abstract: In one embodiment, a system is disclosed. The system includes a wireless data processing device, a messaging service to maintain data objects on behalf of a user, and a data center, coupled to the wireless device and the messaging service. The data center establishes a plurality of routing connections between the wireless device and the messaging service. Each of the plurality of connections corresponds to a data service level authorized by the data center.

Abstract: A system is described in which, under certain conditions, a wireless data processing apparatus and/or the service to which the apparatus communicates, will enter a batch processing mode. Under the batch processing mode, the apparatus and/or service will combine a series of message transactions (e.g., message viewings, message deletions, . . . etc) before synchronizing with the service and/or apparatus, respectively. Various types of batch processing parameters may be set to determine whether the system should enter batch processing mode and/or how batch processing should be performed once batch processing mode has been entered.

Abstract: A manufacturer rebate-processing program uses a program administrator to implement the rebate program. A rebate program card is issued to consumers to identify the rebate-qualifying product. The consumer presents the card to the merchant when making a purchase. The purchase transaction information from the merchant is forwarded to the rebate program administrator, which in turn forwards a rebate request to the manufacturer for the rebate-qualifying product. The rebate-qualifying product may be a prescription drug or a non-prescription health-care-related item. The program administrator further identifies restricted-use accounts, such as health savings accounts, to pay a qualifying portion of the consumer purchase transaction. The program administrator receives rebate funds from the manufacturer and reconciles the consumer purchase transaction with the rebate funds from the manufacturer.

Abstract: According to one embodiment, a handheld device is disclosed. The handheld device includes a housing, a display mounted within the housing, and a font magnification mechanism. The font magnification mechanism automatically magnifies a font being displayed on the display to a larger font whenever the handheld device is operating in dim lighting conditions.

Abstract: A manufacturer rebate processing program uses a program administrator to implement the rebate program. A rebate program card is issued to consumers to identify the rebate qualifying product. The consumer presents the card to the merchant when making a purchase. The purchase transaction from the merchant is forwarded to the rebate program administrator which in turn forwards a rebate request to the manufacturer for the rebate qualifying product. The rebate qualifying product may be a prescription drug or a non-prescription health care item. The program administrator further identifies restricted use accounts such as health savings accounts to pay a qualifying portion of the consumer purchase transaction. The program administrator receives rebate funds from the manufacturer and reconciles the consumer purchase transaction with the rebate funds from the manufacturer. The rebate funds may be deposited into a merchant account or a consumer account to reconcile the consumer purchase transaction.

Abstract: According to one embodiment, a handheld device is disclosed. The handheld device includes a housing, a display mounted within the housing, and a font magnification mechanism. The font magnification mechanism automatically magnifies a font being displayed on the display to a larger font whenever the handheld device is operating in dim lighting conditions.

Abstract: In one embodiment, a server is disclosed. The server includes a messaging service, and an interface communicatively coupled to a wireless device. The interface maintains synchronization of data objects with the wireless device over a wireless network. Further, the server transmits message updates originating at the messaging service to the wireless device and receives message updates originating at the wireless device at the interface.

Abstract: According to one embodiment, a system is disclosed. The system includes a wireless data processing device and a server communicatively coupled to the wireless device. The server comprises mapping logic that translates data objects having a first set of identification (ID) codes to a second set of ID codes for transmission to the wireless device to maintain synchronization of data objects with the wireless device over a wireless network.

Abstract: In one embodiment, a system is disclosed. The system includes a wireless data processing device, a messaging service to maintain data objects on behalf of a user, and a data center, coupled to the wireless device and the messaging service. The data center establishes a plurality of routing connections between the wireless device and the messaging service. Each of the plurality of connections corresponds to a data service level authorized by the data center.

Abstract: A pharmaceutical composition useful in the treatment or prevention of transgenic xenograft rejection comprising immunosuppressant compounds selected from the group consisting of an IL-2 transcription inhibitor and immunosuppressant compounds that immunosuppress for B-cell-mediated or antibody-mediated rejection of xenografts, and pharmaceutically acceptable diluents or carriers, and a method of preventing hyperacute rejection, reducing early graft damage, improving early xenograft function and promoting long term survival of said transgenic xenografts comprising the steps of i) contacting the body fluid removed from a human recipient with a xenoantigenic material which is bound to a biocompatible solid support, ii) reintroducing the treated body fluid into the recipient, and iii) treating the recipient with said pharmaceutical composition.

Abstract: A method for entering and manipulating spreadsheet cell data is described. The present invention provides a method for determining the target cell for written information and for scaling the information to fit within the boundaries of the target cell. A multi-tiered character recognition scheme is used to improve the accuracy and speed of character recognition and translation of handwritten data. The original handwritten data is preserved so that either the translated data or original data may be displayed. The present invention also provides for improved editing of cell entries by allowing a plurality of editing tools to be selected. Manipulation of blocks of data can be accomplished with simple gestures. Arithmetic, statistical and logical functions can be invoked with a single command.

Abstract: A method for entering and manipulating spreadsheet cell data is described. The present invention provides a method for determining the target cell for written information and for scaling the information to fit within the boundaries of the target cell. A multi-tiered character recognition scheme is used to improve the accuracy and speed of character recognition and translation of handwritten data. The original handwritten data is preserved so that either the translated data or original data may be displayed. The present invention also provides for improved editing of cell entries by allowing a plurality of editing tools to be selected. Manipulation of blocks of data can be accomplished with simple gestures. Arithmetic, statistical and logical functions can be invoked with a single command.

Abstract: The present invention provides an improved method for targeting in a computer system. A block of data is identified by analyzing strokes of writing to determine if a current stroke is to be associated with an existing block of data or with a new block of data. Displacement in the X direction and Y direction between a prior stroke and a current stroke is generated and analyzed to determine if a new block of data has been created. After a block of data has been identified, the bounds of the smallest rectangle that contains all of the strokes in the block are determined. The area overlap between the bounded rectangle and every object or field touched by the rectangle is calculated. If a preselected threshold percentage of the bounded rectangle overlaps a single field or object, that field or object is identified as the target.

Abstract: Improved data entry for handwriting entry computer systems, including "delayed translation" of written strokes, is provided. After a user has entered data into a handwriting entry computer system, the writing is associated with a target field or object. In one embodiment of the invention, a translation of the entered data is performed, and the untranslated "ink" is displayed. At a later time, if desired, the user can elect to display the translated text. If there are errors or mistranslations, the user can make corrections or revert back to the ink. In another embodiment, a user enters data into the computer system. A translation of the data is performed by a background process. If any of the characters cannot be translated, the original ink is displayed. If all of the characters are translated, the resultant word is compared to a dictionary of words, numbers and symbols. If the resultant translated word does not match a dictionary entry, the original ink is displayed.